# 21 CFR 520.1453 Moxidectin and praziquantel gel.

21 CFR 520.1453 Moxidectin and praziquantel gel., “Moxidectin and praziquantel gel”, is a CFR section of [21 CFR Part 520—Oral dosage form new animal drugs](https://ontology.bommaritollc.com/id/01a0f094-b871-7674-b63f-921b1e38872d); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS](https://ontology.bommaritollc.com/id/01a0f094-b631-77c0-8360-43217423fdac) › [21 CFR Part 520—Oral dosage form new animal drugs](https://ontology.bommaritollc.com/id/01a0f094-b871-7674-b63f-921b1e38872d)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 520.1453](https://ontology.bommaritollc.com/id/01a0f094-c75c-73f7-9d90-84ff1e0123c9)
- `eli:cites`:
  - [21 CFR 500.25 Anthelmintic drugs for use in animals.](https://ontology.bommaritollc.com/id/01a0f094-c5eb-71e0-bf96-2d0f8c8b615e)
  - [21 CFR 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.](https://ontology.bommaritollc.com/id/01a0f094-c64a-701d-b272-158824f1f54d)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3ace5ae23125)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e3a3-752b-b3e4-319b0ca1a798)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c63f-71b7-8bb6-ba291b9f71f5)
  - [evidence from https://www.govinfo.gov/link/cfr/21/520?sectionnum=1453&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-6901-7696-860b-f14d0ebd7ac7)
- `schema:isPartOf`: [21 CFR Part 520—Oral dosage form new animal drugs](https://ontology.bommaritollc.com/id/01a0f094-b871-7674-b63f-921b1e38872d)
- `schema:legislationIdentifier`: 21 CFR 520.1453
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Moxidectin and praziquantel gel
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/520?sectionnum=1453&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/520?sectionnum=1453&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 520.1453 Moxidectin and praziquantel gel.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/520?sectionnum=1453&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b)
Cite as: 21 CFR 520.1453 Moxidectin and praziquantel gel.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c75b-773a-9fa5-3acfff04443b
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
